In addition to weight loss, semaglutide with B12 has been shown to improve other health markers such as blood pressure, cholesterol levels, and blood sugar control
In mouse models of highfat dietinduced liver steatosis, it significantly inhibits hepatic NNMT activity, reduces NAM methylation, increases NAD+ and SAM levels, enhances mitochondrial fatty acid oxidation, reduces hepatic triglyceride and lipid accumulation, lowers lipotoxicity markers (e.g., malondialdehyde, transaminases), improves hepatocellular injury, and reverses steatosis
Ensuring sufficient B-12 intake is crucial, and these injections offer a quick and effective way to address deficiencies, promoting overall health and wellbeing
Neuron 83 , 518532 (2014)